Pathogenesis guided therapeutic management of COVID-19: an immunological perspective

Ashutosh Kumar1,2, Pranav Prasoon1,3, Prakash S Sekhawat1,4

  • 1Etiologically Elusive Disorders Research Network (EEDRN), New Delhi, India.

Insights

The Coronavirus disease 2019 (COVID-19) pandemic has high mortality due to non-standardized treatments. This review explores host-virus interactions, pathogenic mechanisms, and potential therapeutic strategies for COVID-19.

Area of Science:

  • Immunology
  • Virology
  • Pathology

Background:

  • The Coronavirus disease 2019 (COVID-19) pandemic presents a significant global health challenge, characterized by high mortality rates.
  • A primary driver of this mortality is the lack of standardized therapeutic interventions.
  • Emerging evidence highlights SARS-CoV-2-induced immune cell dysregulation and subsequent tissue damage as key pathological features.

Purpose of the Study:

  • To review the current understanding of host-virus interactions in COVID-19.
  • To deliberate on the plausible pathogenic mechanisms underlying COVID-19.
  • To identify and discuss suitable therapeutic approaches for managing COVID-19.

Main Methods:

  • Literature review of empirical evidence on host-virus interactions.
  • Analysis of emerging data on immune cell dysregulation and tissue injury in COVID-19.
  • Synthesis of information to propose pathogenic mechanisms and therapeutic strategies.

Main Results:

  • Accumulating evidence points to specific immune cell dysregulation as a critical factor in COVID-19 pathogenesis.
  • Tissue injury is a direct consequence of the host's immune response to SARS-CoV-2 infection.
  • While no definitive treatments exist, ongoing clinical trials show promising initial results.

Conclusions:

  • Understanding host-virus interactions is crucial for developing effective COVID-19 therapies.
  • Targeting immune dysregulation and mitigating tissue injury are key therapeutic considerations.
  • Further research into standardized treatment protocols is essential to reduce COVID-19 mortality.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
724
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
93